nodes	percent_of_prediction	percent_of_DWPC	metapath
Alvimopan—Quinapril—Lisinopril—dilated cardiomyopathy	0.501	0.512	CrCrCtD
Alvimopan—Benazepril—Lisinopril—dilated cardiomyopathy	0.477	0.488	CrCrCtD
Alvimopan—Quinapril—ACE—dilated cardiomyopathy	0.00225	0.535	CrCbGaD
Alvimopan—Benazepril—ACE—dilated cardiomyopathy	0.00196	0.465	CrCbGaD
Alvimopan—OPRD1—Peptide GPCRs—AGTR2—dilated cardiomyopathy	0.000466	0.0257	CbGpPWpGaD
Alvimopan—OPRD1—Peptide GPCRs—CXCR3—dilated cardiomyopathy	0.000433	0.0239	CbGpPWpGaD
Alvimopan—OPRK1—Peptide GPCRs—AGTR2—dilated cardiomyopathy	0.000409	0.0226	CbGpPWpGaD
Alvimopan—OPRD1—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.000409	0.0226	CbGpPWpGaD
Alvimopan—OPRK1—Peptide GPCRs—CXCR3—dilated cardiomyopathy	0.00038	0.021	CbGpPWpGaD
Alvimopan—OPRD1—Peptide GPCRs—AGTR1—dilated cardiomyopathy	0.000359	0.0198	CbGpPWpGaD
Alvimopan—OPRK1—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.000358	0.0198	CbGpPWpGaD
Alvimopan—OPRM1—Peptide GPCRs—AGTR2—dilated cardiomyopathy	0.000346	0.0191	CbGpPWpGaD
Alvimopan—OPRM1—Peptide GPCRs—CXCR3—dilated cardiomyopathy	0.000321	0.0177	CbGpPWpGaD
Alvimopan—OPRK1—Peptide GPCRs—AGTR1—dilated cardiomyopathy	0.000314	0.0174	CbGpPWpGaD
Alvimopan—OPRM1—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.000303	0.0167	CbGpPWpGaD
Alvimopan—OPRM1—Peptide GPCRs—AGTR1—dilated cardiomyopathy	0.000266	0.0147	CbGpPWpGaD
Alvimopan—OPRM1—IL4-mediated signaling events—IL10—dilated cardiomyopathy	0.000257	0.0142	CbGpPWpGaD
Alvimopan—OPRM1—IL4-mediated signaling events—RPS6KB1—dilated cardiomyopathy	0.00025	0.0138	CbGpPWpGaD
Alvimopan—OPRD1—Peptide ligand-binding receptors—AGTR2—dilated cardiomyopathy	0.000219	0.0121	CbGpPWpGaD
Alvimopan—OPRD1—Peptide ligand-binding receptors—CXCL2—dilated cardiomyopathy	0.000219	0.0121	CbGpPWpGaD
Alvimopan—OPRD1—Peptide ligand-binding receptors—CXCR3—dilated cardiomyopathy	0.000204	0.0113	CbGpPWpGaD
Alvimopan—OPRK1—Peptide ligand-binding receptors—AGTR2—dilated cardiomyopathy	0.000192	0.0106	CbGpPWpGaD
Alvimopan—OPRK1—Peptide ligand-binding receptors—CXCL2—dilated cardiomyopathy	0.000192	0.0106	CbGpPWpGaD
Alvimopan—OPRD1—G alpha (i) signalling events—AGTR2—dilated cardiomyopathy	0.000185	0.0102	CbGpPWpGaD
Alvimopan—OPRD1—G alpha (i) signalling events—CXCL2—dilated cardiomyopathy	0.000185	0.0102	CbGpPWpGaD
Alvimopan—OPRK1—Peptide ligand-binding receptors—CXCR3—dilated cardiomyopathy	0.000179	0.00987	CbGpPWpGaD
Alvimopan—OPRD1—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	0.000172	0.0095	CbGpPWpGaD
Alvimopan—OPRD1—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.000172	0.00948	CbGpPWpGaD
Alvimopan—OPRM1—TCR Signaling Pathway—FAS—dilated cardiomyopathy	0.000171	0.00942	CbGpPWpGaD
Alvimopan—OPRD1—Peptide ligand-binding receptors—AGTR1—dilated cardiomyopathy	0.000169	0.00931	CbGpPWpGaD
Alvimopan—OPRM1—Peptide ligand-binding receptors—CXCL2—dilated cardiomyopathy	0.000163	0.00897	CbGpPWpGaD
Alvimopan—OPRM1—Peptide ligand-binding receptors—AGTR2—dilated cardiomyopathy	0.000163	0.00897	CbGpPWpGaD
Alvimopan—OPRK1—G alpha (i) signalling events—AGTR2—dilated cardiomyopathy	0.000162	0.00896	CbGpPWpGaD
Alvimopan—OPRK1—G alpha (i) signalling events—CXCL2—dilated cardiomyopathy	0.000162	0.00896	CbGpPWpGaD
Alvimopan—OPRD1—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.00016	0.00881	CbGpPWpGaD
Alvimopan—OPRD1—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.000155	0.00854	CbGpPWpGaD
Alvimopan—OPRM1—Peptide ligand-binding receptors—CXCR3—dilated cardiomyopathy	0.000151	0.00834	CbGpPWpGaD
Alvimopan—OPRK1—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	0.000151	0.00833	CbGpPWpGaD
Alvimopan—OPRK1—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.000151	0.00831	CbGpPWpGaD
Alvimopan—OPRK1—Peptide ligand-binding receptors—AGTR1—dilated cardiomyopathy	0.000148	0.00817	CbGpPWpGaD
Alvimopan—OPRD1—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.000147	0.00812	CbGpPWpGaD
Alvimopan—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.000147	0.00812	CbGpPWpGaD
Alvimopan—OPRK1—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.00014	0.00773	CbGpPWpGaD
Alvimopan—OPRM1—G alpha (i) signalling events—AGTR2—dilated cardiomyopathy	0.000137	0.00757	CbGpPWpGaD
Alvimopan—OPRM1—G alpha (i) signalling events—CXCL2—dilated cardiomyopathy	0.000137	0.00757	CbGpPWpGaD
Alvimopan—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.000137	0.00755	CbGpPWpGaD
Alvimopan—OPRK1—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.000136	0.00748	CbGpPWpGaD
Alvimopan—OPRD1—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.000132	0.00731	CbGpPWpGaD
Alvimopan—OPRD1—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.000132	0.00729	CbGpPWpGaD
Alvimopan—OPRK1—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.000129	0.00712	CbGpPWpGaD
Alvimopan—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.000129	0.00712	CbGpPWpGaD
Alvimopan—OPRM1—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	0.000127	0.00704	CbGpPWpGaD
Alvimopan—OPRM1—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.000127	0.00703	CbGpPWpGaD
Alvimopan—OPRD1—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000125	0.00692	CbGpPWpGaD
Alvimopan—OPRM1—Peptide ligand-binding receptors—AGTR1—dilated cardiomyopathy	0.000125	0.0069	CbGpPWpGaD
Alvimopan—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.00012	0.00662	CbGpPWpGaD
Alvimopan—OPRD1—Peptide ligand-binding receptors—AGT—dilated cardiomyopathy	0.000119	0.00655	CbGpPWpGaD
Alvimopan—OPRM1—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.000118	0.00653	CbGpPWpGaD
Alvimopan—OPRK1—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.000116	0.00641	CbGpPWpGaD
Alvimopan—OPRK1—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.000116	0.00639	CbGpPWpGaD
Alvimopan—OPRM1—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.000115	0.00633	CbGpPWpGaD
Alvimopan—OPRD1—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000113	0.00625	CbGpPWpGaD
Alvimopan—OPRD1—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000112	0.00619	CbGpPWpGaD
Alvimopan—OPRD1—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000112	0.00619	CbGpPWpGaD
Alvimopan—OPRM1—TCR Signaling Pathway—RAF1—dilated cardiomyopathy	0.000111	0.00613	CbGpPWpGaD
Alvimopan—OPRK1—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.00011	0.00606	CbGpPWpGaD
Alvimopan—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.000109	0.00602	CbGpPWpGaD
Alvimopan—OPRM1—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.000109	0.00602	CbGpPWpGaD
Alvimopan—OPRD1—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000107	0.00593	CbGpPWpGaD
Alvimopan—OPRD1—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000104	0.00575	CbGpPWpGaD
Alvimopan—OPRK1—Peptide ligand-binding receptors—AGT—dilated cardiomyopathy	0.000104	0.00575	CbGpPWpGaD
Alvimopan—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.000101	0.0056	CbGpPWpGaD
Alvimopan—OPRD1—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000101	0.00557	CbGpPWpGaD
Alvimopan—OPRD1—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.0001	0.00553	CbGpPWpGaD
Alvimopan—OPRK1—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	9.92e-05	0.00548	CbGpPWpGaD
Alvimopan—OPRK1—GPCR ligand binding—AGTR2—dilated cardiomyopathy	9.82e-05	0.00542	CbGpPWpGaD
Alvimopan—OPRK1—GPCR ligand binding—CXCL2—dilated cardiomyopathy	9.82e-05	0.00542	CbGpPWpGaD
Alvimopan—OPRM1—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	9.81e-05	0.00542	CbGpPWpGaD
Alvimopan—OPRM1—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	9.78e-05	0.0054	CbGpPWpGaD
Alvimopan—OPRK1—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	9.41e-05	0.0052	CbGpPWpGaD
Alvimopan—OPRM1—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	9.28e-05	0.00513	CbGpPWpGaD
Alvimopan—OPRK1—GPCR ligand binding—CXCR3—dilated cardiomyopathy	9.13e-05	0.00504	CbGpPWpGaD
Alvimopan—OPRK1—GPCR ligand binding—ADRB1—dilated cardiomyopathy	8.84e-05	0.00488	CbGpPWpGaD
Alvimopan—OPRM1—Peptide ligand-binding receptors—AGT—dilated cardiomyopathy	8.79e-05	0.00486	CbGpPWpGaD
Alvimopan—OPRK1—G alpha (i) signalling events—AGT—dilated cardiomyopathy	8.78e-05	0.00485	CbGpPWpGaD
Alvimopan—OPRD1—GPCR ligand binding—AGTR1—dilated cardiomyopathy	8.61e-05	0.00476	CbGpPWpGaD
Alvimopan—OPRM1—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	8.38e-05	0.00463	CbGpPWpGaD
Alvimopan—OPRM1—GPCR ligand binding—AGTR2—dilated cardiomyopathy	8.3e-05	0.00458	CbGpPWpGaD
Alvimopan—OPRM1—GPCR ligand binding—CXCL2—dilated cardiomyopathy	8.3e-05	0.00458	CbGpPWpGaD
Alvimopan—OPRD1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	8.17e-05	0.00451	CbGpPWpGaD
Alvimopan—OPRD1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	7.96e-05	0.0044	CbGpPWpGaD
Alvimopan—OPRM1—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	7.95e-05	0.00439	CbGpPWpGaD
Alvimopan—OPRM1—GPCR ligand binding—CXCR3—dilated cardiomyopathy	7.72e-05	0.00426	CbGpPWpGaD
Alvimopan—OPRK1—GPCR ligand binding—AGTR1—dilated cardiomyopathy	7.55e-05	0.00417	CbGpPWpGaD
Alvimopan—OPRM1—GPCR ligand binding—ADRB1—dilated cardiomyopathy	7.47e-05	0.00413	CbGpPWpGaD
Alvimopan—OPRM1—G alpha (i) signalling events—AGT—dilated cardiomyopathy	7.42e-05	0.0041	CbGpPWpGaD
Alvimopan—OPRK1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	7.16e-05	0.00396	CbGpPWpGaD
Alvimopan—OPRK1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	6.98e-05	0.00385	CbGpPWpGaD
Alvimopan—OPRM1—GPCR ligand binding—AGTR1—dilated cardiomyopathy	6.38e-05	0.00352	CbGpPWpGaD
Alvimopan—OPRD1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	6.33e-05	0.0035	CbGpPWpGaD
Alvimopan—OPRD1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	6.33e-05	0.0035	CbGpPWpGaD
Alvimopan—OPRD1—GPCR ligand binding—AGT—dilated cardiomyopathy	6.06e-05	0.00335	CbGpPWpGaD
Alvimopan—OPRM1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	6.06e-05	0.00334	CbGpPWpGaD
Alvimopan—OPRM1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	5.9e-05	0.00326	CbGpPWpGaD
Alvimopan—OPRD1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	5.88e-05	0.00325	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	5.75e-05	0.00317	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	5.75e-05	0.00317	CbGpPWpGaD
Alvimopan—OPRD1—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	5.7e-05	0.00315	CbGpPWpGaD
Alvimopan—OPRK1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	5.55e-05	0.00307	CbGpPWpGaD
Alvimopan—OPRK1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	5.55e-05	0.00307	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	5.34e-05	0.00295	CbGpPWpGaD
Alvimopan—OPRK1—GPCR ligand binding—AGT—dilated cardiomyopathy	5.31e-05	0.00293	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—ADRB1—dilated cardiomyopathy	5.18e-05	0.00286	CbGpPWpGaD
Alvimopan—OPRK1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	5.16e-05	0.00285	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	5.04e-05	0.00278	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	5.04e-05	0.00278	CbGpPWpGaD
Alvimopan—OPRK1—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	5e-05	0.00276	CbGpPWpGaD
Alvimopan—OPRD1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	4.87e-05	0.00269	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	4.69e-05	0.00259	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	4.69e-05	0.00259	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	4.69e-05	0.00259	CbGpPWpGaD
Alvimopan—OPRD1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	4.62e-05	0.00255	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—ADRB1—dilated cardiomyopathy	4.54e-05	0.00251	CbGpPWpGaD
Alvimopan—OPRM1—GPCR ligand binding—AGT—dilated cardiomyopathy	4.49e-05	0.00248	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	4.42e-05	0.00244	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	4.36e-05	0.00241	CbGpPWpGaD
Alvimopan—OPRK1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	4.27e-05	0.00236	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	4.26e-05	0.00235	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	4.26e-05	0.00235	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	4.22e-05	0.00233	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	4.19e-05	0.00232	CbGpPWpGaD
Alvimopan—OPRK1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	4.05e-05	0.00224	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	3.96e-05	0.00219	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	3.88e-05	0.00214	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—ADRB1—dilated cardiomyopathy	3.84e-05	0.00212	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—PSEN2—dilated cardiomyopathy	3.82e-05	0.00211	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	3.68e-05	0.00203	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	3.61e-05	0.00199	CbGpPWpGaD
Alvimopan—OPRD1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	3.58e-05	0.00198	CbGpPWpGaD
Alvimopan—OPRD1—GPCR downstream signaling—AGT—dilated cardiomyopathy	3.42e-05	0.00189	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	3.42e-05	0.00189	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—AGTR2—dilated cardiomyopathy	3.4e-05	0.00188	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—CXCL2—dilated cardiomyopathy	3.4e-05	0.00188	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—PSEN2—dilated cardiomyopathy	3.35e-05	0.00185	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	3.28e-05	0.00181	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—RAC1—dilated cardiomyopathy	3.26e-05	0.0018	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—CXCR3—dilated cardiomyopathy	3.16e-05	0.00174	CbGpPWpGaD
Alvimopan—OPRK1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	3.14e-05	0.00174	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—AGT—dilated cardiomyopathy	3.11e-05	0.00172	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	3.11e-05	0.00172	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—ADRB1—dilated cardiomyopathy	3.06e-05	0.00169	CbGpPWpGaD
Alvimopan—OPRK1—GPCR downstream signaling—AGT—dilated cardiomyopathy	3e-05	0.00166	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—AGTR2—dilated cardiomyopathy	2.98e-05	0.00164	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—CXCL2—dilated cardiomyopathy	2.98e-05	0.00164	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—RAC1—dilated cardiomyopathy	2.85e-05	0.00158	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—PSEN2—dilated cardiomyopathy	2.83e-05	0.00157	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—CXCR3—dilated cardiomyopathy	2.77e-05	0.00153	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—AGT—dilated cardiomyopathy	2.73e-05	0.00151	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—ADRB1—dilated cardiomyopathy	2.68e-05	0.00148	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	2.66e-05	0.00147	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—AGTR1—dilated cardiomyopathy	2.61e-05	0.00144	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—AGT—dilated cardiomyopathy	2.54e-05	0.0014	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CXCL2—dilated cardiomyopathy	2.52e-05	0.00139	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—AGTR2—dilated cardiomyopathy	2.52e-05	0.00139	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—ADRB2—dilated cardiomyopathy	2.48e-05	0.00137	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—RAC1—dilated cardiomyopathy	2.41e-05	0.00133	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CXCR3—dilated cardiomyopathy	2.34e-05	0.00129	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—AGT—dilated cardiomyopathy	2.3e-05	0.00127	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—AGTR1—dilated cardiomyopathy	2.29e-05	0.00126	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—ADRB1—dilated cardiomyopathy	2.27e-05	0.00125	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—ADRB2—dilated cardiomyopathy	2.17e-05	0.0012	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—RAF1—dilated cardiomyopathy	2.16e-05	0.00119	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	2.13e-05	0.00118	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.93e-05	0.00107	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—RAC1—dilated cardiomyopathy	1.92e-05	0.00106	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.89e-05	0.00105	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.87e-05	0.00103	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—AGT—dilated cardiomyopathy	1.84e-05	0.00101	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.84e-05	0.00101	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—RAC1—dilated cardiomyopathy	1.69e-05	0.000931	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—AGT—dilated cardiomyopathy	1.61e-05	0.00089	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.6e-05	0.000883	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.58e-05	0.000871	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.48e-05	0.000817	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—RAC1—dilated cardiomyopathy	1.43e-05	0.000787	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—AGT—dilated cardiomyopathy	1.36e-05	0.000752	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.3e-05	0.000717	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—RAF1—dilated cardiomyopathy	1.28e-05	0.000704	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—RAF1—dilated cardiomyopathy	1.12e-05	0.000617	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.1e-05	0.000606	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—RAF1—dilated cardiomyopathy	9.45e-06	0.000522	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—EGFR—dilated cardiomyopathy	8.74e-06	0.000483	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—EGFR—dilated cardiomyopathy	7.67e-06	0.000423	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—EGFR—dilated cardiomyopathy	6.48e-06	0.000358	CbGpPWpGaD
